SEC Company Response from Propanc Biopharma, Inc. (PPCB) (CIK 0001517681) (PPCB) — Dec 4, 2015
Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)
Date: Dec. 4, 2015 · CIK: 0001517681 · Accession: 0001144204-15-069461
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-208169
Letter
Propanc Health Group Corporation
Level 2, 555 Riversdale Road
Camberwell, VIC, 3124 Australia
Tel. No.: +61 (0)3 9882 0780
December 4, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Propanc Health Group Corporation (the “Company)
Registration Statement on Form S-1
File No. 333-208169 (the “Registration Statement”)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 3:00 pm on Tuesday, December 8, 2015, or as soon thereafter as is practicable.
The Company acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Propanc Health Group Corporation
Show Raw Text
CORRESP
1
filename1.htm
Propanc Health Group Corporation
Level 2, 555 Riversdale Road
Camberwell,
VIC, 3124 Australia
Tel. No.: +61 (0)3 9882 0780
December 4, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Propanc Health Group Corporation (the “Company)
Registration Statement on Form
S-1
File No. 333-208169 (the “Registration
Statement”)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred
to above be accelerated so that it will be declared effective at 3:00 pm on Tuesday, December 8, 2015, or as soon thereafter as
is practicable.
The Company acknowledges that:
· should the Commission or the staff, acting
pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with
respect to the filing;
· the action of the Commission or the staff,
acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility
for the adequacy and accuracy of the disclosure in the filing; and
· the company may not assert staff comments
and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Very truly yours,
Propanc Health Group Corporation
By:
/s/ James Nathanielsz
Name:
James Nathanielsz
Title:
Chief Executive Officer